Pfizer Amgen: That Pfizer’s Seagen Bet Could Lead
Pfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
A clear look at the stablecoins that outperformed peers this year, with insights into drivers and risk considerations for future allocations.
26,211 articlesPfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
As memory prices surge in 2026, Corsair Gaming emerges as the leading beneficiary with improved margins, a new buybac...
Webull’s March-quarter results reveal a bold pivot: the CEO says B2B revenue could rival or surpass retail in the com...
A fintech stock surged in recent years, then faced a pullback during down weeks. This article outlines a disciplined ...
Two data-focused tech players, Palantir and BigBear.ai, report quarterly numbers that investors watch closely. This g...
A little-known micro-cap trading under $30 is drawing renewed investor interest as quarterly results show improving p...
Investors chasing steady income weigh higher-yield ETFs against core dividend funds as rates move. This piece explore...
Broadcom’s custom silicon advantage dominates the AI hardware beat, delivering outsized revenue growth while Marvell ...
An AI-driven forecast dubbed the premium Claude Model Fable flags a $100K Bitcoin price target by year-end 2026, even...
NVIDIA is expected to report a $65.7 billion Q4 revenue figure as investors weigh margin recovery against AI-driven d...
A widely watched energy- income ETF offers monthly-like payouts but comes with uneven distributions and a yield below...
When a company's CFO divests shares amid a strong stock run, investors want to know what it means. This deep dive exp...